Related Experiment Video
Updated: Aug 1, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Guillain-Barré as an autoimmune disease
Y Shoenfeld1, J George, J B Peter
1Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
International Archives of Allergy and Immunology
|April 1, 1996
Summary
Guillain-Barré syndrome (GBS) involves immune-mediated demyelination of peripheral nerves. This review explores the complex immune mechanisms, including humoral and cell-mediated pathways, contributing to GBS pathogenesis.
Area of Science:
- Neuroimmunology
- Peripheral Nervous System Disorders
Background:
- Guillain-Barré syndrome (GBS) is characterized by peripheral nervous system demyelination.
- The precise etiopathogenesis of GBS remains under investigation, with increasing evidence implicating immune system involvement.
Purpose of the Study:
- To review current knowledge on the complex immune mechanisms underlying GBS pathogenesis.
- To elucidate the relative significance of humoral and cell-mediated immune pathways in GBS.
Main Methods:
- Literature review of recent advancements in GBS research.
- Analysis of evidence supporting immune system roles in GBS.
Main Results:
- Substantial evidence supports the immune system's role in initiating and perpetuating nerve damage in GBS.
- Humoral immune pathways are increasingly recognized alongside cell-mediated mechanisms in disrupting peripheral nerves.
Conclusions:
- The immune system, encompassing both humoral and cell-mediated responses, plays a critical role in GBS pathogenesis.
- Further understanding of these complex interactions is crucial for GBS management and treatment strategies.
More Related Videos
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...